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Research Article
Body Size, Physical Activity, Early-Life Energy Restriction,
and Associations with Methylated Insulin-like Growth
Factor–Binding Protein Genes in Colorectal Cancer
Colinda C.J.M. Simons1, Piet A. van den Brandt1, Coen D.A. Stehouwer2, Manon van Engeland3, and
Matty P. Weijenberg1
Abstract
Background: We investigated body size, physical activity, and early-life energy restriction in relation to
colorectal tumors with and without methylated insulin-like growth factor–binding protein (IGFBP) genes,
which are putative tumor-suppressor genes.
Methods:We determined IGFBP2, IGFBP3, and IGFBP7 promoter CpG island hypermethylation in tumors
of 733 colorectal cancer cases from the Netherlands Cohort Study (N ¼ 120,852). Participants self-reported
lifestyle and dietary factors at baseline in 1986. Using a case–cohort approach (N subcohort ¼ 5,000), we
estimated hazard ratios (HR) for colorectal cancer by extent of IGFBP methylation.
Results: Comparison of the highest versus lowest sex-specific tertiles of adult body mass index (BMI) gave
multivariable-adjusted HRs [95% confidence intervals (CI)] for colorectal cancers with 0 (18.7%), 1 (29.5%), 2
(32.4%), and 3 (19.5%) methylated genes of 1.39 (0.88–2.19), 1.11 (0.77–1.62), 1.67 (1.17–2.38), and 2.07 (1.29–
3.33), respectively. Other anthropometric measures and physical activity were not associated with colorectal
cancer risk by extent of IGFBP methylation, except height in sex-specific analyses for women. Exposure to
energy restriction during the Dutch Hunger Winter versus nonexposure gave HRs (95% CIs) for colorectal
cancers with 0, 1, 2, and 3 methylated genes of 1.01 (0.67–1.53), 1.03 (0.74–1.44), 0.72 (0.52–0.99), and 0.50
(0.32–0.78), respectively.
Conclusions:Adult BMI, height (in women only), and early-life energy restriction were associated with the
risk of having a colorectal tumor characterized by IGFBP methylation.
Impact: Body size may particularly increase the risk of IGFBP gene–methylated colorectal tumors; this
finding might facilitate more targeted approaches to prevent obesity-related colorectal cancers. Cancer
Epidemiol Biomarkers Prev; 23(9); 1852–62. 2014 AACR.
Introduction
The insulin-like growth factor (IGF) pathway regu-
lates growth by affecting cell proliferation, differentia-
tion, and apoptosis, and has long been thought one of
the mechanisms through which overweight and a lack
of physical activity increase colorectal cancer risk (1).
The IGF pathway includes IGFI and -II, of which IGFI is
the main growth factor in adult life, IGF binding pro-
teins (IGFBP-1–6), and IGFBP-related proteins (IGFBP-
7–10).
We focus on IGFBP-1–7, which have been most
studied. In the context of this article, we view IGFBPs
as putative tumor suppressors with local effects in
colorectal tissue. Traditionally, IGFBPs have been
viewed as carrier proteins that transport IGFs through
the circulatory system, extending their half-lives and
preventing them from reaching target tissues until
released. In this way, IGFBPs regulate IGF bioavailabil-
ity (2, 3). Today, IGFBPs have been shown to have
numerous actions that can be endocrine (via the circu-
latory system), paracrine, autocrine, and intranuclear.
Actions can be IGF-dependent and IGF-independent (i.
e., IGFBPs may act alone or bind to other molecules;
refs. 4, 5). Growth stimulatory effects are not excluded,
although IGFBPs are best known for their growth-
suppressing effects (4,5).
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Considering their role as tumor suppressors, silencing
of IGFBP genes through promoter hypermethylation like-
ly counteracts the growth inhibitory effect conferred by
IGFBPs. The evidence for this includes studies showing
growth inhibition in cell lines of hepatocellular, breast,
and melanoma cancer characterized by promoter hyper-
methylation of IGFBP3 in response to demethylating
agents and/or histone deacetylase inhibitors (5). IGFBP
methylation has, furthermore, been indicated an unfavor-
able event in cancer development, including colorectal
cancer development, by cell studies investigating meth-
ylation of IGFBP1 (6), IGFBP2 (7), IGFBP3 (6), IGFBP4 (7),
and IGFBP7 (8–11). Finally, IGFBP1 methylation levels in
peripheral blood were recently found increased in type II
diabetic men compared with normal glucose-tolerant
individuals (12). Type II diabetics as compared with
nondiabetics have been found to be at an increased risk
of colorectal cancer (13).
Because methylation is an early event in colorectal
tumorigenesis (14), we hypothesized that promoter CpG
island hypermethylation of IGFBP genes could sensitize
individuals to the effects of colorectal cancer risk factors
such as overweight and physical activity. Therefore, with-
in the prospective Netherlands Cohort Study (NLCS), we
studied body size, physical activity, and early-life energy
restriction in relation to the extent of IGFBPmethylation in
colorectal tumors. We hypothesized that a larger body
size increases the risk of having a colorectal tumor with
methylated IGFBP genes but not without methylated
IGFBP genes. We hypothesized that physical activity
and early-life energy restriction decrease the risk of hav-
ing a colorectal tumor with methylated IGFBP genes but
not without methylated IGFBP genes. In addition, we
explored relationships between IGFBP methylation,
microsatellite instability (MSI; ref. 15), and theCpG island
methylator phenotype (CIMP; ref. 16), because MSI and
CIMP involve methylation of several tumor suppressor-
and DNA repair genes. IGFBPmethylation might, there-
fore, tag MSI or CIMP phenotypes, which may be
reflected in correlations between IGFBP methylation on
the one hand and MSI and CIMP phenotypes on the
other hand.
Materials and Methods
Study population and design
The NLCS (17) includes 120,852 participants, sampled
from 204 Dutch municipalities, who were 55 to 69 years
old at baseline in 1986.At baseline, participants completed
a self-administered questionnaire, including a semi-quan-
titative 150-item food frequency questionnaire (FFQ). The
FFQwas found to rank individuals adequately according
to dietary intake as compared with a 9-day dietary record
(18) andwas shown a good indicator of intake for at least 5
years (19,20). Participants who reported a history of can-
cer (other than skin cancer)were excluded. TheNLCSwas
approved by the review boards of the TNONutrition and
Food Research Institute and Maastricht University in the
Netherlands.
The NLCS is characterized by a case–cohort
approach. This approach entails that a random subco-
hort (N ¼ 5,000)—selected immediately after baseline
and representative of the whole cohort—is followed up
to estimate the person-time at risk, whereas incident
cancer cases are enumerated for the entire cohort. Sub-
cohort members contribute to the person-time at risk
until the end of follow-up, cancer incidence, death, or
loss to follow-up. Follow-up for vital status is per-
formed through linkage to the Central Bureau of Gene-
alogy and the municipal population registries (100%
completeness). Cancer follow-up is performed through
linkage with the population-based cancer registry and
PALGA (Netherlands pathology database; >96% com-
pleteness; refs. 21–23). In the period 1989 to 1993 (the
follow-up period used for the current analyses), 939
incident colorectal cancer cases occurred. Sufficient
tumor DNA, isolated from formalin-fixed, paraffin-
embedded sections after macro-dissection of tumor
cells, was available for 733 cases (Fig. 1). Age at diag-
nosis, tumor sublocalization (ICD-O-1 153), and tumor
node metastasis (TNM) stage were retrieved from the
cancer registry.
Body size, physical activity, and early-life energy
restriction
Adult bodymass index [BMI; weight (kg)/height (m)2],
BMI at age 20, BMI change since age 20, height (cm), and
adult trouser/skirt size were derived from the baseline
questionnaire. Adult BMI, BMI at age 20, and height were
categorized into sex-specific tertiles.Wedeviated from the
BMI categorization of the World Health Organization
(WHO) that distinguishes between underweight (<18.5
kg/m2), normal weight (18.5–<25 kg/m2), overweight
(25–<30 kg/m2), and obese individuals (30 kg/m2;
ref. 24), because of power considerations. Adult trou-
ser/skirt size was shown to correlate well with hip and
waist circumferences in a subset of weight-stable indivi-
duals, andwas associatedwith endometrial and renal cell
cancer risk in a fashion as would be expected for waist
circumference, rendering it a good proxy (25).
Nonoccupational physical activity at baseline in min-
utes per day was a sum measure of several activities. It
included daily walking/cycling (min/d), weekly recrea-
tional walking/cycling, weekly engagement in garden-
ing/odd jobs, and weekly participation in sports/gym-
nastics (categories: never, 1, 1–2, and>2h/wk).Categories
were 30, >30–60, >60–90, and >90 min/d. In the present
article, the two middle categories were combined for
power considerations. Occupational physical activitywas
derived from self-reported occupational history on the
basis of a rating system developed by Hettinger (26),
which distinguishes between jobs with an energy expen-
diture of <8, 8–12, and >12 kJ/min. Occupational physical
activity was representative of long-term physical activity
in men and used in sex-specific analyses for men only,
because a substantial number of women were never
employed or only in the distant past (27).
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Early-life energy restriction was measured through
three proxy variables: the place of residence during the
Hunger Winter (1944–45); the place of residence in 1942,
reflecting the war years (1940–44); and the employment
status of an individual’s father during the economic
depression (1932–40). Nutritional differences during
these periods have been well documented in the Nether-
lands. In particular, living in aWestern city in the Nether-
lands during the Hunger Winter indicated severe energy
restriction. The Dutch Hunger Winter was preceded by a
German food embargo and was unusually early and
harsh; by the time the embargo was (partially) lifted, the
canals had frozen over, which made it impossible to
transport food into the Western parts of the country, and
11 cities are considered famine cities: Amsterdam, Rot-
terdam, The Hague, Utrecht, Zaandam, Hilversum,
Amersfoort, Dordrecht, Vlaardingen/Schiedam, Delft,
and Leiden. At the height of the famine, from December
1944 to April 1945, official daily rations per capita were
between 400 and 800 kilocalories, although the diet
remained nutritionally balanced (28, 29). During the eco-
nomic depression, sufficient calories were available, but
the variation in the food pattern had likely been limited if
an individual’s father was unemployed. NLCS partici-
pants were between 12 and 28 years old during the
Hunger Winter, between 8 and 28 years old during the
war years, and between 0 and 23 years old during the
economic depression.
Data on adult BMI, BMI at age 20, BMI change, adult
trouser/skirt size, height, nonoccupational physical activ-
ity, occupational physical activity, place of residence
during the Hunger Winter, place of residence during
World War II, and employment status of an individual’s
father during the economic depression were complete for
96.1%, 82.0%, 81.8%, 93.4%, 96.7%, 98.0%, 87.1%, 87.3%,
72.6%, and 93.9% of subcohort members, respectively.
Laboratory analyses
IGFBP methylation. We determined IGFBP2,
IGFBP3, IGFBP4, and IGFBP7 CpG island promoter
hypermethylation by methylation-specific PCR (MSP;
refs. 30, 31) after bisulfite modification of 500 ng DNA
(ZymoResearch), becausemethylation had been reported
in these IGFBP genes before this study. To facilitate MSP
on DNA retrieved from formalin-fixed, paraffin-embed-
ded tissue, DNA was first amplified with flanking PCR
primers that amplify bisulfite-modified DNA, but do not
preferentially amplifymethylated or unmethylatedDNA.
The resulting fragmentwasusedas a template for theMSP
reaction. All PCRs were carried out with controls for
unmethylated alleles (DNA from normal lymphocytes),
methylated alleles [normal lymphocyte DNA treated in
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Histologically confirmed CRC cases identified by PALGA in the period
4 CRC cases excluded because of linkage update
PALGA report available
Tissue collected from pathology laboratories*
Sufficient tumor material available as judged by an experienced pathologist
1 CRC case excluded because of linkage update
1989–1993; the follow-up before 1989 was excluded because of incomplete
coverage by PALGA
Figure 1. Flow chart of colorectal cancer cases available for analysis. CRC, colorectal cancer. , Tumor tissuewas collected after approval by the ethical review
boards of Maastricht University, the population-based cancer registry, and PALGA; the pathology laboratories made available the tumor blocks between
August 1999 and December 2001.
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vitrowith SssImethyltransferase (NewEngland Biolabs)],
and a control without DNA. Ten microliters of each MSP
reaction was directly loaded on to a nondenaturing 2%
agarosegel, stainedwith gelstar, andvisualizedunderUV
illumination. Primersweredesigned on the basis of a deep
sequencing analysis of methylation in colon cancer cell
lines, to precisely cover densely methylated CpG islands
(14). IGFBP4 methylation analyses were discontinued
after preliminary results showedmethylation in only four
out of 100 samples. We concluded that IGFBP4 methyla-
tion is rare in colorectal cancer and that analyses would
not be cost effective. The primer sequences used to ana-
lyze IGFBP2, IGFBP3, and IGFBP7 are shown in Supple-
mentary Table S1. Methylation analyses of IGFBP2,
IGFBP3, and IGFBP7were successful in 98.9%, 94.4%, and
98.0% of 733 colorectal cancer cases, respectively; repro-
ducibility in duplo or triplo analyses was 93.2% (N ¼ 103
sample pairs/trios), 95.1% (N ¼ 122 sample pairs/trios),
and 84.4% (N ¼ 77 sample pairs/trios), respectively.
CIMP and MSI. CIMP was defined by CpG island
promoter hypermethylation of 3 out of five Weisenber-
ger markers (CACNA1G, IGF2, NEUROG1, RUNX3, and
SOCS1; ref. 32). Methylation of these markers was ana-
lyzed using MSP as described previously (33). Analyses
were successful in 81%, 79%, 79%, 90%, and 83% of 733
cases for CACNA1G, IGF2, NEUROG1, RUNX, and
SOCS1, respectively. MSI was determined by a common
approach: a pentaplex PCR using the mononucleotide
repeats BAT-26, BAT-25, NR-21, NR-22, and NR-24. Alle-
lic size variations in 3 repeats were a marker for MSI;
other tumorswere classified asmicrosatellite stable (MSS;
ref. 34). Analyses were successful in 90% of 733 cases.
Statistical analysis
We used Cox regression to estimate hazard ratios (HR)
and 95% confidence intervals (CI) for colorectal cancer
risk by extent of IGFBP methylation in relation to body
size, physical activity, and early-life energy restriction
using Stata (Stata Corp.). The risk of colorectal cancer by
methylation status of IGFBP2, IGFBP3, and IGFBP7 was
estimated for future literature comparisons. To account
for the additional variance introduced by sampling the
subcohort from the entire cohort, standard errors were
estimated using the robust Huber–White sandwich esti-
mator. A P value < 0.05 for two-sided testing indicated
statistical significance. The proportional hazards assump-
tion was tested using the scaled Schoenfeld residuals and
by visually inspecting the -log-log-transformed hazard
curves. No violations were detected.
We modeled risk with an age- and sex-adjusted model,
and with multivariable-adjusted models, which included
predefined potential confounders. Other potential con-
founders were included if these changed HRs by >10%.
None of the variables considered did [family history of
colorectal cancer, smoking status, socioeconomic status,
diabetes, total energy intake, and intake of alcohol, meat,
processedmeat, fruit, vegetables, fiber, fat (energy-adjust-
ed), water through foods and fluids, supplements, folate,
beta-carotene, vitamin B6, vitamin C, vitamin E, calcium,
iron, magnesium, flavonoids, and catechins]. The adjust-
ments made in each model are presented in Table 1. With
respect to BMI change, analyses were stratified by adult
BMI (<25 and 25 kg/m2) in an effort to disentangle the
potential effect of weight gain on colorectal cancer risk
from that of being overweight or obese in adulthood (BMI
change correlated with adult BMI in subcohort members,
Pearson r ¼ 0.68; P < 0.001). Individuals with a negative
BMI change were excluded in this analysis (N ¼ 492), as
there were too few cases among these individuals (N¼ 51
in total) to establish a separate category within strata of
adult BMI andby extent of IGFBPmethylation. Separating
this groupmaybe important as someweight gainwith age
may be expected, and severe weight loss might even
indicate preclinical disease (the mean BMI change in
subcohort members was 3.5 kg/m2 with a SD of 3.4
kg/m2).
Sensitivity analyses were performed to check for inde-
pendent effects of adult BMI and BMI at age 20, a medi-
ating effect of BMI at age 20 inmodels for early-life energy
restriction, and a potential influence of timing of exposure
to early-life energy restriction. An overview is given
in Table 1. We also performed sex-specific analyses, even
though the power to detect associations was limited,
because previous NLCS data about colorectal cancer risk




Methylation of IGFBP genes was successfully analyzed
in 652 colorectal cancer cases. The prevalence of IGFBP2,
IGFBP3, and IGFBP7 methylation was 40.6% (N ¼ 265),
40.2% (N ¼ 262), and 71.8% (N ¼ 468), respectively. An
IGFBPmethylation index showed that 18.7% (N¼ 122) of
colorectal cancer cases had 0 methylated genes, 29.5% (N
¼ 192) had 1 methylated gene, 32.4% (N ¼ 211) had 2
methylated genes, and 19.5% (N¼ 127) had 3 methylated
genes. The investigated exposures did not evidently differ
between subcohort members and colorectal cancer cases
(Table 2).
The distribution of colorectal cancer cases across
the IGFBPmethylation index significantly differed from
that across instability types as based on CIMP and
MSI status (P < 0.001; Table 3). The percentage of MSI
tumors (of which 76.9% also had CIMP) and MSS CIMP
tumors increased with an increasing number of meth-
ylated IGFBP genes (þ17.4% and þ36.3%, respectively),
whereas the percentage of MSS non-CIMP tumors
decreased across IGFBP index groups (53.7%). All
three instability groups were present among colorectal
cancers with 3 methylated IGFBP genes: 24.5% of colo-
rectal cancer cases were MSI tumors, 38.7% were MSS
CIMP tumors, and 36.8% were MSS non-CIMP tumors.
With increasing methylated IGFBP gene numbers, the
tumor location was more often proximal and less often
distal (P < 0.001). Age at diagnosis and TNM stage did
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not significantly differ by extent of IGFBP methylation
(P ¼ 0.98 and 0.08, respectively).
Colorectal cancer risk by extent of IGFBP
methylation
Adult BMI and early-life energy restriction were
associated with colorectal cancers with several methyl-
ated IGFBP genes after multivariable corrections (Table
4). For adult BMI, comparison of the highest versus
lowest sex-specific tertiles gave HRs (95% CIs) for colo-
rectal cancers with 0, 1, 2, and 3 methylated genes of 1.39
(0.88–2.19), 1.11 (0.77–1.62), 1.67 (1.17–2.38), and 2.07
(1.29–3.33), respectively. Significant linear trends were
observed in associations between adult BMI and colo-
rectal cancers with 2 and 3 methylated genes (P < 0.01).
Adult BMI modeled per 5-unit increase corroborated
the observed associations. BMI at age 20, BMI change
since age 20 modeled in strata of adult BMI, height,
adult trouser/skirt size, and nonoccupational physical
activity were not associated with colorectal cancer risk
by IGFBP methylation status, although there was a
borderline significant inverse trend across nonoccupa-
tional physical activity categories in relation to colorec-
tal cancer with 3 methylated IGFBP genes (P trend ¼
0.06). Exposure to early-life energy restriction during
the Hunger Winter versus nonexposure gave HRs (95%
CIs) for colorectal cancers with 0, 1, 2, and 3 methylated
IGFBP genes of 1.01 (0.67–1.53), 1.03 (0.74–1.44), 0.72
(0.52–0.99), and 0.50 (0.32–0.78), respectively. A simi-
larly decreased HR for colorectal cancer with 3 meth-
ylated IGFBP genes was observed in those exposed to
energy restriction during the war years versus those
nonexposed (HR, 0.59; 95% CI, 0.39–0.89). Having
had an unemployed father during the economic depres-
sion was not significantly associated with any of the
endpoints, yet strong inverse HRs were observed for
colorectal cancers with 2 and 3 methylated IGFBP genes
(HR, 0.59; 95% CI, 0.35–1.02 and HR, 0.59; 95% CI, 0.30–
1.19, respectively). Additional adjustment for adult
BMI in models for BMI at age 20 and vice versa did
not essentially change results, nor did additional adjust-
ment for BMI at age 20 in models for early-life energy
restriction (data not shown). Age-stratified analyses
for early-life energy restriction did not reveal essential
differences in associations between individuals exposed
at young or later age in early life, although there
was diminished power in these analyses (data not
shown).
In sex-specific analyses, shown in the Supplementary
Tables S2 and S3, adult BMI was significantly associated
with an increased risk of colorectal cancer with several
methylated IGFBP genes inmen but notwomen, although
HRs in women were nonsignificantly increased. Height
was significantly associated with an increased risk of
colorectal cancer with several methylated IGFBP genes
in women, but not men. Other indicators of body size and
(non)occupational physical activity were not associated
with colorectal cancer risk by IGFBP methylation status,
Table 1. Overview of the tested models, adjustments, and sensitivity analyses
Model Adjustment Sensitivity analysis
Adult BMI Age, sex, and nonoccupational physical
activity
Additional adjustment for
BMI at age 20
BMI at age 20 Age, sex, and nonoccupational physical
activity
Additional adjustment for adult BMI
BMI change in strata of adult BMI Age, sex, and nonoccupational physical
activity
Height Age, sex, nonoccupational physical activity,
and weight
Adult trouser/skirt size Age, sex, nonoccupational physical activity,
and adult BMI
Nonoccupational physical activity Age, sex, and adult BMI
Occupational physical activity
(used in sex-specific
analyses for men only)
Age, sex, and adult BMI
Early-life energy restriction during the
Hunger Winter
Age, sex, and adult BMI 1) Additional adjustment for
BMI at age 20; 2) age-stratified
analysis
Early-life energy restriction during the
war years
Age, sex, and adult BMI 1) Additional adjustment for
BMI at age 20; 2) age-stratified
analysis
Early-life energy restriction during the
economic depression
Age, sex, and adult BMI 1) Additional adjustment for
BMI at age 20; 2) age-stratified
analysis
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although there was a significant association between BMI
at age 20 measured per 5-unit increase and colorectal
cancers with 2 (but not 3) methylated genes in men.
Early-life energy restriction was significantly inversely
associatedwithhaving severalmethylated IGFBPgenes in
colorectal cancer in men and women. Supplementary
Table 4 shows results by IGFBP2, IGFBP3, and IGFBP7
methylation status to aid future literature comparison.
Overall, these analyses were difficult to interpret as sig-
nificant associationswere not specific to colorectal cancers
Table 2. Characteristics of subcohort members and colorectal cancer cases in the NLCS (1989–1993)
Subcohort members Colorectal cancer casesa
N (%) Mean (SD) N (%) Mean (SD)
Overall 4,658 (100) 652 (100)
Case characteristics
IGFBP2 methylated 265 (40.6)
IGFBP3 methylated 262 (40.2)
IGFBP7 methylated 468 (71.8)
IGFBP methylation index
0 genes methylated 122 (18.7)
1 gene methylated 192 (29.5)
2 genes methylated 211 (32.4)




Men 25.0 (2.6) 25.5 (2.8)
Women 25.1 (3.5) 25.7 (3.6)
BMI at age 20, kg/m2
Men 21.8 (2.4) 22.0 (2.3)
Women 21.4 (2.8) 21.5 (2.5)
BMI change since age 20, kg/m2
Men þ3.3 (3.0) þ3.5 (3.0)
Women þ3.7 (3.7) þ4.1 (3.7)
Height, cm
Men 176.4 (6.7) 176.8 (6.9)
Women 165.1 (6.2) 166.4 (6.4)
Adult trouser/skirt size
<median, sex-specific 1,694 (40.5) 189 (33.0)
median 2,486 (59.5) 384 (67.0)
Physical activity
Nonoccupational physical activity
30 min/d 995 (22.5) 131 (21.3)
30–90 2,270 (51.4) 318 (51.7)
>90 1,150 (26.1) 166 (27.0)
Early-life energy restriction
Exposure to the Hunger Winter (1944–45)
Non-Western area 2,255 (58.0) 335 (63.7)
Western area 1,631 (42.0) 191 (36.3)
Exposure to the war years (1940–44)
Rural area 1,573 (48.4) 244 (51.4)
Urban area 1,679 (51.6) 231 (48.6)
Economic depression (1932–40)
Employed 3,702 (88.3) 534 (90.7)
Unemployed 492 (11.7) 55 (9.3)
aCases with successful IGFBP2, IGFBP3, and IGFBP7 methylation analyses.
bNumbers are excluding missing values on adult BMI and nonoccupational physical activity.
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with methylated IGFBP genes, but were also observed for
colorectal cancers with unmethylated IGFBP genes.
Discussion
This is the first study suggesting that adult BMI,
height (in women only), and early-life energy restriction
predict preferentially for colorectal tumors character-
ized by IGFBP-methylated genes. This study is an exam-
ple of a molecular pathologic epidemiologic study in
which dietary or lifestyle risk factors are investigated in
relation to molecular changes in tumors (37). To fully
appreciate our findings, absolute values of BMI should
be considered. Using WHO criteria as a reference (24),
we report that 97.2% of the participants in the lowest
tertile in this study fell within the normal adult weight
range (BMI, 18.5–<25.0 kg/m2), and 80.3% of the parti-
cipants in the highest tertile fell within the overweight
range (BMI, 25.0–<30.0 kg/m2). The significantly
increased HRs for adult BMI were, thus, based on a
fairly small contrast in BMI. Although we must be
careful extrapolating findings, stronger associations
may be expected in populations with a higher obesity
prevalence if these allow for a larger BMI contrast to be
made. With respect to BMI at age 20, 92.3% of the study
participants had a BMI <25.0 kg/m2, and it may be that
there was too little contrast between individuals to
detect associations.
Our results should be interpreted with caution
because validation of our findings is needed. To our
knowledge, there are no other experimental or observa-
tional data on body size, physical activity, and early-life
energy restriction in relation to IGFBP methylation in
colorectal tumors. The advantage of measuring IGFBP
methylation instead of IGFBP expression in colorectal
tumors is that methylation likely represents enduring
change. However, the actual amount of bioavailable
IGFBPs in the tumor may also depend on the influx of
IGFBPs from the circulatory system and on factors such
as IGFBP proteases (3), growth hormone, and insulin (2),
and may, thus, be better reflected by IGFBP expression
levels. Therefore, the investigation of body size, physical
activity, and energy restriction in relation to IGFBP
expression levels in colorectal tumors may be informa-
tive in addition to validation of the present results.
Studies focusing on tissue-specific expression levels
could also explain inconsistent findings with respect to
associations between IGFBP blood levels and colorectal
cancer risk (2, 38, 39), as IGFBP blood levels may not
necessarily correlate with tissue-specific levels.












Tumor instability type, N (%)
MSI (including CIMP) 6 (7.1) 9 (5.9) 24 (14.4) 26 (24.5)
MSS CIMP 2 (2.4) 19 (12.5) 37 (22.2) 41 (38.7)
MSS non-CIMP 76 (90.5) 124 (81.6) 106 (63.5) 39 (36.8)
P for x2 test <0.001a
Clinical characteristics
Age at diagnosis (y), mean (SD) 67.8 (4.5) 67.9 (3.9) 67.9 (4.5) 68.1 (4.1)
P for Kruskal–Wallis test 0.98
Tumor localization, N (%)
Proximal colon 29 (24.4) 47 (25.1) 73 (35.3) 64 (52.0)
Distal colon 43 (36.1) 74 (39.6) 70 (33.8) 21 (17.1)
Rectosigmoid 15 (12.6) 25 (13.4) 18 (8.7) 12 (9.8)
Rectum 32 (26.9) 41 (21.9) 46 (22.2) 26 (21.1)
P for x2 test <0.001a
TNM stage, N (%)
Stage 1 6 (5.3) 14 (8.0) 17 (8.9) 11 (9.2)
Stage 2 30 (26.6) 36 (20.5) 42 (22.0) 19 (16.0)
Stage 3 69 (61.1) 120 (68.2) 119 (62.3) 73 (61.3)
Stage 4 8 (7.1) 6 (3.4) 13 (6.8) 16 (13.5)
P for x2 test 0.08
aRemained statistically significant after a Bonferroni correction for multiple testing.
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Table 4. Multivariable-adjusted HRs and 95% CIs for colorectal cancer by extent of IGFBPmethylation in




























T1, sex-specificb 7,181 33 1 (Reference) 56 1 (Reference) 53 1 (Reference) 27 1 (Reference)
T2 7,059 34 1.04 (0.64–1.69) 61 1.10 (0.76–1.59) 64 1.22 (0.84–1.77) 37 1.39 (0.84–2.29)
T3 7,079 45 1.39 (0.88–2.19) 61 1.11 (0.77–1.62) 87 1.67 (1.17–2.38) 57 2.07 (1.29–3.33)
P trend 0.16 0.57 0.004 0.002
Adult BMI, per 5 kg/m2 21,319 112 1.26 (0.93–1.71) 178 1.19 (0.93–1.53) 204 1.39 (1.11–1.74) 121 1.34 (1.07–1.67)
BMI at age 20, kg/m2
T1, sex-specificc 6,187 28 1 (Reference) 49 1 (Reference) 48 1 (Reference) 26 1 (Reference)
T2 5,991 32 1.19 (0.71–2.00) 55 1.17 (0.79–1.73) 63 1.37 (0.93–2.02) 38 1.53 (0.92–2.53)
T3 6,030 35 1.32 (0.80–2.18) 42 0.90 (0.59–1.37) 60 1.32 (0.90–1.95) 33 1.35 (0.80–2.27)
P trend 0.27 0.64 0.15 0.25
BMI at age 20, per 5 kg/m2 18,208 95 1.16 (0.81–1.65) 146 1.07 (0.79–1.45) 171 1.23 (0.94–1.60) 97 1.27 (0.91–1.78)
BMI change, per kg/m2d
Stratum: adult BMI
<25 kg/m2
7,895 36 0.98 (0.81–1.18) 62 0.86 (0.74–1.01) 59 0.90 (0.80–1.02) 34 0.87 (0.72–1.05)
Stratum: adult BMI
25 kg/m2
8,209 49 1.00 (0.99–1.14) 73 1.00 (0.91–1.10) 97 1.03 (0.95–1.12) 55 0.94 (0.85–1.05)
Height, cm
T1, sex-specifice 7,756 38 1 (Reference) 55 1 (Reference) 60 1 (Reference) 38 1 (Reference)
T2 7,261 42 1.12 (0.71–1.77) 60 1.13 (0.77–1.64) 66 1.05 (0.73–1.51) 36 0.93 (0.58–1.48)
T3 6,301 32 0.91 (0.56–1.49) 63 1.29 (0.86–1.95) 78 1.23 (0.84–1.79) 47 1.25 (0.77–2.01)
P trend 0.73 0.22 0.28 0.36
Height, per 5 cm 21,319 112 0.94 (0.81–1.10) 178 1.02 (0.90–1.16) 204 1.05 (0.93–1.19) 121 1.11 (0.95–1.30)
Adult trouser/skirt size
<Median, sex-specific 8,230 41 1 (Reference) 57 1 (Reference) 57 1 (Reference) 34 1 (Reference)
Median 11,964 63 0.91 (0.57–1.43) 112 1.25 (0.86–1.82) 131 1.22 (0.84–1.75) 78 1.26 (0.78–2.04)
Physical activity
Nonoccupational physical activity, min/d
30 4,747 22 1 (Reference) 33 1 (Reference) 42 1 (Reference) 34 1 (Reference)
>30–90 11,002 58 1.21 (0.74–1.99) 86 1.18 (0.79–1.78) 109 1.18 (0.82–1.70) 65 0.90 (0.59–1.38)
>90 5,569 32 1.26 (0.73–2.19) 59 1.55 (1.00–2.38) 53 1.05 (0.69–1.60) 22 0.59 (0.33–1.03)
P trend 0.42 0.04 0.87 0.06
Early-life energy restriction
Hunger Winter (1944–45)
Non-Western area 10,891 57 1 (Reference) 88 1 (Reference) 117 1 (Reference) 73 1 (Reference)
Western area 7,899 41 1.01 (0.67–1.53) 65 1.03 (0.74–1.44) 59 0.72 (0.52–0.99) 26 0.50 (0.32–0.78)
War years (1940–44)
Rural area 7,572 37 1 (Reference) 68 1 (Reference) 80 1 (Reference) 59 1 (Reference)
Urban area 8,148 49 1.21 (0.78–1.89) 67 0.89 (0.63–1.27) 77 0.90 (0.65–1.25) 38 0.59 (0.39–0.89)
Economic depression
(1932–40)
Employed 17,900 99 1 (Reference) 147 1 (Reference) 182 1 (Reference) 106 1 (Reference)
Unemployed 2,367 10 0.72 (0.37–1.41) 21 1.04 (0.65–1.67) 15 0.59 (0.35–1.02) 9 0.59 (0.30–1.19)
Abbreviations: PY, person-years at risk; T, tertile.
aAdjusted for age and sex. In addition, all models, except models for nonoccupational physical activity, were adjusted for nonoccupational
physical activity; models for adult trouser/skirt size, nonoccupational physical activity, and early-life energy restriction were adjusted for adult
BMI; models for height were adjusted for adult weight.
bThe range in sex-specific tertiles of adult BMIwas 16.1–23.9, 23.9–25.9, and 25.8–39.7 kg/m2 inmen and 14.5–23.5, 23.4–26.2, and 26.1–41.6
kg/m2 in women.
cThe range in sex-specific tertiles of BMI at age 20was 12.0–20.8, 20.7–22.6, and 22.6–31.9 kg/m2 inmen and 13.0–20.3, 20.2–22.5, and 22.4–
46.9 kg/m2 in women.
dExcluding individuals with a negative BMI change since age 20. The range in BMI change was 0–12.1 and 0–11.5 kg/m2 in men and
women, respectively, with an adult BMI <25 kg/m2, and 0–19.1 and 0–22.7 kg/m2 in men and women, respectively, with an adult BMI 25
kg/m2.
eThe range in sex-specific tertiles of height was 147–173, 174–179, and 180–200 cm in men and 140–163, 164–168, and 169–186 cm in
women.
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It is relatively unclear how IGFBP methylation corre-
lates with CIMP andMSI, and whether observed associa-
tions might be confounded by alterations underlying
methylation in general. CIMP and MSI are important
phenotypes in colorectal cancer associated with methyl-
ation of tumor suppressor- and DNA repair genes. Pre-
viously, IGFBP7 methylation correlated positively with
CIMP (40), as did IGFBP3 methylation, especially with
MSS CIMP tumors (15). IGFBP3 methylation has also
been used as a CIMP marker (41). We observed that the
percentage of MSI and MSS CIMP tumors increased with
increasing numbers of methylated IGFBP genes, but that
still 36.8% of colorectal cancer cases with 3 methylated
IGFBP genes had MSS non-CIMP tumors. It might, there-
fore, be argued that IGFBP methylation does not simply
tag MSI and CIMP phenotypes. This may be reflected in
subtle differences in associations with body size, physical
activity, and early-life energy restriction. Using NLCS
data, MSI in colorectal cancer has been associated with
height (42). CIMP in colorectal cancer was associated
with early-life energy restriction (33) and BMI at age
20, but not adult BMI (43). We discussed in these articles
that findings of associations between BMI at age 20, early-
life energy restriction, and epigenetic changes in tumors
may be logical, considering that epigenetic changes gen-
erally occur early in colorectal tumorigenesis (14) and
considering that obesity has been associated with a
chronic state of low-grade inflammation (44, 45), which
in turn has been associatedwithmethylation (46). If, thus,
viewing epigenetic changes as intermediary to BMI and
colorectal cancer, it seems plausible that body size in
early life but not later life is associated with epigenetic
changes. Other case–control studies found associations
between BMI and MSS tumors but not MSI tumors (47)
and between BMI and MSI-stable and MSI-low tumors
but not MSI-high tumors (48). Furthermore, associations
have been reported between BMI and CIMP-low colon
tumors, but not CIMP-high colon tumors (49). No asso-
ciations were observed between BMI and CIMP-high or
-low rectal tumors (50). Given that MSI and CIMP phe-
notypes correlate strongly and groups are likely to over-
lap (51), these findings suggest that adult BMI is not
associated with MSI and CIMP, which are thought to
reflect methylation on a broader scale. In the present
study, adult BMI and early-life energy restriction were
associated with IGFBP methylation in colorectal cancer
when analyzing men and women together. Sex-specific
analyses in addition revealed associations with height in
women. Associations were repeatedly in the hypothe-
sized direction. These apparently contradictory results
might also indicate that IGFBP methylation does not
simply tag MSI and CIMP phenotypes in colorectal
cancer. We should, therefore, consider the possibility
that a phenotype characterized by several methylated
IGFBP genes shares underlying factors with MSI and
CIMP that cause methylation, but that this phenotype
does not share other factors that eventually determine
MSI and CIMP.
In terms of the potential relevance of these results for
public health, future research may focus on whether
markers such as IGFBP methylation can be detected in
colorectal polyps and is representative of a defect likely to
occur in future lesions. If so, this would open up the
exciting possibility of the use of these markers as a bio-
marker for identifying individuals who might benefit
from weight gain prevention. The significance of such
potential benefit should be investigated in carefully
designed intervention studies. So far, methylation has
been shown an early event in colorectal tumorigenesis,
but the methylation status of multiple adenomas (N¼ 78)
within the same patients (N ¼ 26) in a study on CIMP
using the methylation markers p16,MINT2, and MINT31
correlated weakly (52). However, this study did not
include sessile serrated adenomas, and it may be impor-
tant to focus on this adenoma type because these lesions
often develop through a pathway characterized by meth-
ylation (53), whereas methylation might be more random
in other lesions.
Major strengths of this study include the prospective
design and completeness of follow-up, making selection
and information bias unlikely. A particular strength is
also that we based the primer location for determining
IGFBP methylation on deep-sequencing results for
methylation in colon cell lines, ensuring that primers
covered methylation "hot spots." A limitation may be
that subsite-specific associations could not be studied
because of limited power, even though this study is
among the largest prospective studies assessing molec-
ular characteristics in colorectal cancer. A limitation
may also be the single baseline measurement obtained
by self-reports. However, self-reports of body size have
been shown to have good validity (54), and our mea-
sures of physical activity cover a considerable period
in the lives of study participants, which may be impor-
tant as colorectal cancer development is a process of
decades.
To conclude, adult BMI, height (in women only), and
early-life energy restriction were associated with the risk
of having a colorectal tumor characterized by IGFBP
methylation. The findings as described in this article
might eventually facilitate more targeted approaches to
prevent obesity-related colorectal cancers.
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